Physiologic concentrations of inorganic phosphate accelerate fructosamine synthesis
The effect of physiologic concentrations of inorganic phosphate (Pi) on fructosamine (FRA) synthesis was studied. After 75 g oral glucose administration (OGTT), ‘ ΔFRA 24 h ’, defined as ΔFRA after incubating serum or other specimens at 37°C for 24 h after adding 1000 mg/dl glucose, was significantl...
Saved in:
Published in | Diabetes research and clinical practice Vol. 17; no. 1; pp. 9 - 16 |
---|---|
Main Authors | , , |
Format | Journal Article |
Language | English |
Published |
Shannon
Elsevier Ireland Ltd
01.07.1992
Elsevier Science |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | The effect of physiologic concentrations of inorganic phosphate (Pi) on fructosamine (FRA) synthesis was studied. After 75 g oral glucose administration (OGTT), ‘
ΔFRA
24 h
’, defined as ΔFRA after incubating serum or other specimens at 37°C for 24 h after adding 1000 mg/dl glucose, was significantly decreased in parallel to the decrease of plasma Pi concentrations. ‘The FRA index’, defined as the FRA value divided by the corresponding glucose concentration, both at fasting, correlated significantly with plasma Pi concentrations. In vitro incubation of serum total protein (TP), albumin (ALB), γ-globulin (GLB), free lysine (Lys), and free valine (Val) with glucose at different concentrations of Pi showed a Pi-dependent increase of FRA synthesis throughout 48 h of incubation. The accelerating effect of 5 mg/dl Pi on FRA synthesis from TP, ALB, GLB, Lys, and Val at pH 7.4 was, respectively, as great as 48, 20, 24, 13 or 25% of those without Pi. Increase of pH from 6 to 10 logarithmically increased
ΔFRA
24 h
in contrast to a logarithmic decrease of the accelerating effect of Pi on
ΔFRA
24 h
. These data show that physiologic concentrations of Pi accelerate protein glycation by accelerating dehydrogenation during the Amadori rearrangement through the negative charge of Pi. Because this accelerating effect of physiologic Pi presumably exists in vivo, Pi concentration must be taken into account as an accelerating factor for FRA synthesis in evaluating diabetic control, and further studies must be carried out to elucidate whether hyperphosphatemia accelerates glycation-induced diabetic complications. |
---|---|
Bibliography: | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
ISSN: | 0168-8227 1872-8227 |
DOI: | 10.1016/0168-8227(92)90038-S |